Chris Sarchi

Chris Sarchi joined Replimune as Chief Commercial Officer in December of 2022. Chris brings over 30 years of experience in the pharmaceutical industry, with 28 years dedicated to the field on Oncology working at GSK, Roche/Genentech, Boehringer-Ingelheim, and most recently at Sanofi where he served as the General Manager and Head of Oncology in the US. He has been involved with 9 new product launches in oncology covering multiple tumor types, as well as supportive care products. Among these milestones, Chris led Libtayo’s launch as a new standard of care in CSCC, and was also involved with the launch of Erivedge in Basel Cell Carcinoma while at Genentech. Chris received a Bachelor of Science in Business Administration from the University of Maine.